MEPOLIZUMAB
mepolizumab 100 mg/mL injection, 1 mL pen device
MEPOLIZUMAB (12064Y)
12064Y
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $1,556.10 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Nucala | |||||